These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52. Reduced insulin sensitivity during growth hormone therapy for short children born small for gestational age. Cutfield WS, Jackson WE, Jefferies C, Robinson EM, Breier BH, Richards GE, Hofman PL. J Pediatr; 2003 Feb; 142(2):113-6. PubMed ID: 12584529 [Abstract] [Full Text] [Related]
56. Growth hormone treatment strategy for short children born small for gestational age. Czernichow P. Horm Res; 2004 Feb; 62 Suppl 3():137-40. PubMed ID: 15539815 [Abstract] [Full Text] [Related]
57. d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype. Montefusco L, Filopanti M, Ronchi CL, Olgiati L, La-Porta C, Losa M, Epaminonda P, Coletti F, Beck-Peccoz P, Spada A, Lania AG, Arosio M. Clin Endocrinol (Oxf); 2010 May; 72(5):661-7. PubMed ID: 20447065 [Abstract] [Full Text] [Related]
58. Growth hormone receptor sequence changes do not play a role in determining height in children with idiopathic short stature. Hujeirat Y, Hess O, Shalev S, Tenenbaum-Rakover Y. Horm Res; 2006 May; 65(4):210-6. PubMed ID: 16582564 [Abstract] [Full Text] [Related]
59. Optimal use of growth hormone therapy for maximizing adult height in children born small for gestational age. Simon D, Léger J, Carel JC. Best Pract Res Clin Endocrinol Metab; 2008 Jun; 22(3):525-37. PubMed ID: 18538291 [Abstract] [Full Text] [Related]
60. The d3/fl-GH receptor gene polymorphism does not influence quality of life and body composition in GH-deficient adults receiving GH replacement therapy. Adetunji OR, MacFarlane IA, Javadpour M, Alfirevic A, Pirmohamed M, Blair JC. Eur J Endocrinol; 2009 Oct; 161(4):541-6. PubMed ID: 19605543 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]